Boehringer Challenges Medicare Drug Price Negotiation Law
Boehringer Ingelheim Pharmaceuticals Inc. has filed another in a string of constitutional challenges to the Inflation Reduction Act, arguing that the U.S. Department of Health and Human Services is derailing drug...To view the full article, register now.
Already a subscriber? Click here to view full article